Incyte Corporation ($INCY) Stock Forecast: Down % Today. Incyte (NASDAQ:INCY) Stock, Analyst Ratings, Price Targets, Forecasts. Incyte Corp has a consensus price target of $ based on the ratings of 24 analysts. INCY Forecast/Price Target ; High · $ ; Low · $ ; Average · $ INCY's current price target is $ Learn why top analysts are making this stock forecast for Incyte at MarketBeat. Discover Incyte's earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers.
Wall Street analysts forecast INCY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INCY. Is Incyte Stock Undervalued? The current Incyte [INCY] share price is $ The Score for INCY is 43, which is 14% below its historic median score of Incyte price target raised to $92 from $86 at Guggenheim. Sep. 16, at a.m. ET on missia-udm.ru Stifel Nicolaus Keeps Their Hold Rating on Incyte (INCY). Incyte is forecasted to increase in value after the next headline, with the price projected to jump to or above. The average volatility of media hype. Projected Stock Price. $ ↑%. Estimated share price by August 6, ; Projected Revenue. 1, MM ↑%. Estimated quarterly revenue by December Get Incyte Corp (INCY:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Find the latest Incyte Corporation (INCY) stock quote, history, news and other vital information to help you with your stock trading and investing. INCY Price · $ ; Market Cap · $B ; 52 Week Low · $ ; 52 Week High · $ ; P/E · x. Stock INCY INCYTE CORPORATION. PDF Report. Consensus Incyte Corporation. Equities. INCY. USC Pharmaceuticals. Market Closed - Nasdaq. Other stock. See Incyte Corporation (INCY) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades Analyst Price Targets. Low. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. Bid Price and Ask Price. The bid & ask refers to the price that an.
On average, Wall Street analysts predict that Incyte's share price could reach $ by Sep 3, The average Incyte stock price prediction forecasts a. View Incyte Corporation INCY stock quote prices, financial information, real-time forecasts, and company news from CNN. We've gathered analysts' opinions on Incyte Corporation future price: according to them, INCY price has a max estimate of USD and a min estimate of Based on short-term price targets offered by 18 analysts, the average price target for Incyte comes to $ The forecasts range from a low of $ to a. The Incyte Corp. stock prediction for is currently $ , assuming that Incyte Corp. shares will continue growing at the average yearly rate as they did. Over the last 12 months, its price rose by percent. Looking ahead, we forecast Incyte Corp to be priced at by the end of this quarter and at in. The average price target is $ with a high estimate of $92 and a low estimate of $ Given the current short-term trend, the stock is expected to rise % during the next 3 months and, with a 90% probability hold a price between $ and. Stock Price Forecast. The 15 analysts with month price forecasts for Incyte stock have an average target of , with a low estimate of 48 and a high.
View the INCY premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Incyte Corporation real. What was Incyte Corp's price range in the past 12 months? Incyte Corp lowest stock price was $ and its highest was $ in the past 12 months. INCY EPS for the last quarter is − USD despite the estimation of USD. In the next quarter EPS is expected to reach USD. Track more of Incyte. 29 analysts offering month price forecasts for Incyte Corporation (INCY) have a share price target of $ This median of share price forecast represents. Incyte Corporation Price History · - INCY Stock was down % · - INCY Stock was up % · - INCY Stock was down % ·
Incyte. INCY ; 8. Funds holding · of 6, funds ; Analysts bullish · of 16 analysts ; News positive · of 11 articles.
Incyte Stock: Shares Have Taken a Beating in 2018 – Here’s Why